Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CNTG

Centogene (CNTG) Stock Price, News & Analysis

Centogene logo

About Centogene Stock (NASDAQ:CNTG)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.07
$0.35
52-Week Range
N/A
Volume
8.36 million shs
Average Volume
150,868 shs
Market Capitalization
$8.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CNTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centogene and its competitors with MarketBeat's FREE daily newsletter.

CNTG Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
CNTGF Centogene N.V.
Centogene N.V. (CNTG)
See More Headlines

CNTG Stock Analysis - Frequently Asked Questions

Centogene (NASDAQ:CNTG) released its quarterly earnings results on Wednesday, November, 24th. The company reported ($1.08) EPS for the quarter, missing analysts' consensus estimates of ($0.59) by $0.49. The company had revenue of $35.60 million for the quarter, compared to analysts' expectations of $31.91 million.

Centogene (CNTG) raised $60 million in an IPO on Thursday, November 7th 2019. The company issued 4,000,000 shares at $14.00-$16.00 per share. SVB Leerink and Evercore ISI served as the underwriters for the IPO and Baird and BTIG were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Centogene investors own include Avino Silver & Gold Mines (ASM), Lincoln National (LNC), Advanced Micro Devices (AMD), Applied Genetic Technologies (AGTC), Catalyst Pharmaceuticals (CPRX), Fulcrum Therapeutics (FULC) and VBI Vaccines (VBIV).

Company Calendar

Last Earnings
11/24/2021
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NASDAQ:CNTG
Fax
N/A
Employees
810
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$48.54 million
Price / Cash Flow
N/A
Book Value
($1.01) per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$8.80 million
Optionable
Not Optionable
Beta
-0.67
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:CNTG) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners